Vistagen TherapeuticsVTGN
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 55 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings, down 3 from Q3 2025. 13 opened new positions and 16 sold out. The largest holders were Orbimed Advisors LLC ($2.0M), TCG Crossover Management, LLC ($1.8M) and Vanguard Group Inc. ($1.2M). 3 famous investors held it, including Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Vistagen Therapeutics Inc.
- CUSIP
- 92840H400
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $519K |
| Exits | 16 | $32.2M |
All 13F filers, Q3 2025 → Q4 2025: 2,466,636 shares bought and 12,097,467 shares sold, net −9,630,831 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 55 holders
| Orbimed Advisors LLC | 0.04% | No change | 3,060,000 | $2.0M |
| TCG Crossover Management, LLC | 0.06% | No change | 2,676,580 | $1.8M |
| Vanguard Group Inc. | 0.00% | Add +8.1% | 1,824,738 | $1.2M |
| ADAR1 Capital Management, LLC | 0.03% | Add +451.5% | 623,575 | $413K |
| Jane Street Group, LLC | 0.00% | Add +74.2% | 527,127 | $349K |
| Ikarian Capital, LLC | 0.04% | Reduce -16.4% | 519,077 | $344K |
| BlackRock, Inc. | 0.00% | Reduce -0.1% | 422,759 | $280K |
| Geode Capital Management, LLC | 0.00% | Add +18.3% | 352,836 | $234K |
| Luminus Management LLC | 0.21% | New | 350,000 | $232K |
| Susquehanna International Group, LLP | 0.00% | Add +291.1% | 334,786 | $222K |
| AdvisorShares Investments LLC | 0.03% | Add +20.9% | 250,188 | $166K |
| Stempoint Capital LP | 0.02% | Reduce -75.2% | 616,749 | $142K |
| Millennium Management | 0.00% | Add +853.0% | 197,045 | $130K |
| Two Sigma Investments, LP | 0.00% | Reduce -32.4% | 195,570 | $129K |
| Renaissance Technologies | 0.00% | Reduce -61.9% | 160,791 | $106K |
| Dimensional Fund Advisors LP | 0.00% | Add +123.3% | 151,874 | $101K |
| Two Sigma Advisers, LP | 0.00% | Reduce -12.3% | 137,732 | $91K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -31.7% | 134,571 | $89K |
| State Street Corp. | 0.00% | Add +25.0% | 121,114 | $80K |
| Group One Trading LLC | 0.00% | Add +266.9% | 106,137 | $70K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 103,400 | $68K |
| Diadema Partners LP | 0.04% | Reduce -71.4% | 100,000 | $66K |
| Tudor Investment Corporation | 0.00% | New | 76,172 | $50K |
| Northern Trust Corp. | 0.00% | Add +51.1% | 72,655 | $48K |
| Seven Fleet Capital Management LP | 0.03% | — | 62,701 | $42K |
| Qube Research & Technologies Ltd | 0.00% | New | 60,139 | $40K |
| Occudo Quantitative Strategies LP | 0.00% | Add +38.3% | 59,038 | $39K |
| UBS Group AG | 0.00% | Add +102.6% | 51,993 | $34K |
| American Century Companies Inc. | 0.00% | Add +18.7% | 48,770 | $32K |
| Virtu Financial LLC | 0.00% | New | 37,739 | $25K |
| HRT Financial LP | 0.00% | New | 37,585 | $24K |
| Engineers Gate Manager LP | 0.00% | New | 30,490 | $20K |
| Persistent Asset Partners Ltd | 0.01% | Reduce -64.7% | 26,612 | $18K |
| Kestra Advisory Services, LLC | 0.00% | Add +29.9% | 26,033 | $17K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 23,302 | $15K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +99.7% | 21,736 | $14K |
| HighTower Advisors, LLC | 0.00% | Reduce -1.0% | 20,628 | $14K |
| Lighthouse Investment Partners, LLC | 0.00% | New | 20,580 | $14K |
| Marshall Wace, LLP | 0.00% | New | 19,973 | $13K |
| Truvestments Capital LLC | 0.00% | Add +96.3% | 16,992 | $11K |
| Caption Management, LLC | 0.00% | New | 16,770 | $11K |
| StoneX Group Inc. | 0.00% | New | 13,349 | $9K |
| Morgan Stanley | 0.00% | Reduce -54.0% | 12,658 | $8K |
| DRW Securities, LLC | 0.00% | New | 10,000 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 8,564 | $6K |
| Osaic Holdings, Inc. | 0.00% | Add +28.7% | 5,269 | $3K |
| Bank of America Corp. | 0.00% | Reduce -90.9% | 3,145 | $2K |
| Performa Ltd (US), LLC | 0.00% | No change | 1,000 | $662 |
| MAI Capital Management | 0.00% | No change | 526 | $349 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.7% | 288 | $191 |
| Jones Financial Companies LLLP | 0.00% | No change | 114 | $75 |
| Fairman Group, LLC | 0.00% | No change | 29 | $19 |
| JPMorgan Chase & Co. | 0.00% | Reduce -100.0% | 16 | $11 |
| BNP Paribas Financial Markets | 0.00% | Reduce -76.8% | 13 | $9 |
| Cwm, LLC | 0.00% | No change | 582 | $0 |
"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.